Transgenomic Inc Share Price OTC Bulletin Board
Equities
TBIO
US89365K2069
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
05-14 | Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Precipio, Inc. announced that it expects to receive $0.5 million in funding | CI |
Sales 2022 | 9.41M 737M | Sales 2023 | 15.2M 1.19B | Capitalization | 9.23M 723M |
---|---|---|---|---|---|
Net income 2022 | -12M -939M | Net income 2023 | -5M -391M | EV / Sales 2022 | 1.12 x |
Net cash position 2022 | 2.05M 161M | Net cash position 2023 | 386K 30.22M | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.88% |
Latest transcript on Transgenomic Inc
Managers | Title | Age | Since |
---|---|---|---|
Ilan Danieli
CEO | Chief Executive Officer | 52 | 27/06/17 |
Matthew Gage
DFI | Director of Finance/CFO | 57 | 30/06/17 |
Ayman Mohamed
CTO | Chief Tech/Sci/R&D Officer | 40 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Andrews
BRD | Director/Board Member | 64 | 28/02/21 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 08/08/18 |
Richard Sandberg
CHM | Chairman | 81 | 02/12/19 |
1st Jan change | Capi. | |
---|---|---|
-31.81% | 15.32B | |
-57.92% | 2.08B | |
+20.62% | 1.9B | |
-26.04% | 1.23B | |
+19.52% | 1.21B | |
+0.29% | 777M | |
-37.53% | 717M | |
-39.55% | 689M | |
-29.95% | 587M |
- Stock Market
- Equities
- PRPO Stock
- TBIO Stock